Navigation Links
Expression Injectable by Enhancement Medical – Adverse Events: AttorneyOne Monitors and Keeps Consumers Informed
Date:8/8/2014

San Diego, CA (PRWEB) August 08, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Expression Injectable.

The FDA issued a safety communication on August 5, on adverse events associated with the unapproved use of the Expression product as a dermal filler. Expression is used as an intranasal splint, intended to minimize bleeding and swelling and to prevent adhesions between the septum and the nasal cavity.

FDA’s reason for the safety communication is that the Agency became aware of adverse events, related to unapproved use, that included itching, discoloration, redness, bruising, pain, bumps, lumps, firmness, tenderness, swelling, and the development of hard nodules.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds, “We are determined to keep an eye on FDA announcements concerning Expression Injectable and inform the public. For that reason," he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

The FDA recommends that “health care providers stop using Expression by Enhancement Medical LLC as a subcutaneously administered substance and instead use the list of FDA approved fillers.” And the Agency adds “patients who have received treatment with Expression as a dermal filler should be monitored for adverse events and referred for corrective treatment when appropriate.”

AttorneyOne.com has further information on Expression Injectable at the website including latest major drug, food, and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/08/prweb12077689.htm.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12081219.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Barriers to obtaining gene expression profiling test heightened perceived value
2. Overexpression of Notch1 in temporal lobe epilepsy
3. TAG-1 induces apoptosisrelated gene expression without triggering glioma apoptosis
4. Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression
5. Variable gene expression in zebrafish
6. Occludin and connexin 43 expression in the pathogenesis of traumatic brain edema
7. Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence
8. Researchers report a complete description of gene expression in the human retina
9. Advancement in Biologic Protein Expression Webinar Hosted by Selexis SA
10. Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence
11. McHugh Plastic Surgery & Secret Expressions Med Spa Offer Injection Day Specials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... EBSCO Information Services (EBSCO) ... for Health and Care Excellence (NICE) framework. The agreement allows purchasers from ... to search, order and purchase medical and healthcare-related content through GOBI ®, ...
(Date:2/23/2017)... Nevada (PRWEB) , ... February 23, 2017 , ... Dr. ... Avenue in Henderson, NV 89052. Dr. Mahon was named a 2017 Top Patient Rated ... Doctors is an online directory that recognizes local physicians and dentists who have ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in clinical trials, today announced that Premier Research, a leading clinical development service ... Clinical trials are becoming increasingly complex, due in part to an array of ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... and community for those in the fight against cancer, has produced a seminal ... success. HRA will release top-line findings in a webinar, Defining Compassionate Care ...
(Date:2/23/2017)... ... (PRWEB) February ... for the nation to come together to combine its favorite ... with its favorite fruit – apples! To celebrate National Nutrition ... join the “Apple Madness” bracket tournament – a five-week, five-round ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  In conjunction with DURECT Corporation,s (Nasdaq: ... release, you are invited to listen to a conference ... on Tuesday, March 14, 2017 at 4:30 pm Eastern ... audio webcast of the presentation will be available by ... "Investor Relations."  If you are unable to participate during ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 Report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2015 through ... markets. Market data and analytics are derived from primary and ...
Breaking Medicine Technology: